Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment. Wharton S, Aronne LJ, Stefanski A, Alfaris NF, et al. N Engl J Med 2025 Sep 16. doi: 10.1056/NEJMoa2511774.

Read + Share

Amedeo Smart

Independent Medical Education

Wharton S, Aronne LJ, Stefanski A, Alfaris NF, et al. Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment. N Engl J Med 2025 Sep 16. doi: 10.1056/NEJMoa2511774.
PMID: 40960239